American Depositary Shares Archives | Be Korea-savvy
LexinFintech Holdings Ltd. Announces Full Exercise of Underwriters’ Over-Allotment Option

LexinFintech Holdings Ltd. Announces Full Exercise of Underwriters’ Over-Allotment Option

SHENZHEN, China, Jan. 7 (Korea Bizwire) — LexinFintech Holdings Ltd. (“Lexin” or the “Company”) (NASDAQ:LX), a leading online consumer finance technology platform for educated young adults in China, today announced that the underwriters of the Company’s initial public offering (the “IPO”) have exercised their over-allotment option in full to purchase an additional 1,800,000 American depositary [...]

GW Pharmaceuticals Announces Proposed Public Offering of ADSs

GW Pharmaceuticals Announces Proposed Public Offering of ADSs

LONDON, Dec. 5 (Korea Bizwire) — GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW” or the “Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced today that it intends to sell, subject to market and other conditions, $225 million of American Depositary Shares (“ADSs”) representing ordinary shares of [...]

RedHill Biopharma Announces Closing of Public Offering of its American Depositary Shares

RedHill Biopharma Announces Closing of Public Offering of its American Depositary Shares

TEL-AVIV, Israel and RALEIGH, N.C., Nov. 13 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary drugs for gastrointestinal and inflammatory diseases and cancer, today announced the closing of its previously announced underwritten public offering of [...]

RedHill Biopharma Prices Public Offering of its American Depositary Shares

RedHill Biopharma Prices Public Offering of its American Depositary Shares

TEL-AVIV, Israel and RALEIGH, N.C., Nov. 8 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary drugs for gastrointestinal and inflammatory diseases and cancer, today announced the pricing of its previously announced underwritten public offering for [...]

RedHill Biopharma Announces Proposed Public Offering of its American Depositary Shares

RedHill Biopharma Announces Proposed Public Offering of its American Depositary Shares

TEL-AVIV, Israel and RALEIGH, N.C., Nov. 7 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary drugs for gastrointestinal and inflammatory diseases and cancer, today announced that it intends to offer its American Depositary Shares (“ADSs”), [...]

RedHill Biopharma Announces Withdrawal of Public Offering of its American Depositary Shares

RedHill Biopharma Announces Withdrawal of Public Offering of its American Depositary Shares

TEL-AVIV, Israel, Nov. 2 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily focused on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory diseases and cancer, today announced that it has withdrawn the proposed underwritten public offering of its American [...]